Hepatitis in Developing Countries: Still a Scourge.

Journal Title: Journal of Medical Sciences - Year 2017, Vol 20, Issue 2

Abstract

Screening is defined as the application of a diagnostic test to an asymptomatic population in order to detect a disease at a stage when intervention may improve its outcome and natural history.1 In simpler terms, screening is a strategy that is used in a population to identify the likely presence of an as-yet-undiagnosed sickness in individuals without its signs or symptoms. By itself, screening tests are somewhat unusual in that they are performed on people who are apparently in good health. However, screening interventions are intended for early identification of disease in a population, that may enable earlier intervention and treatment. The idea is to reduce mortality and suffering from a disease through early detection and management. Whereas screening may lead to an earlier diagnosis, the testing may not necessarily prove beneficial to person being screened. Apart from the issues of over- and mis-diagnosis, and inappropriate use or overuse, screening may create a false sense of security. Though screening strategies are never designed to be diagnostic, how to deal with false positive and false negative results remains an issue.

Authors and Affiliations

Shariq R. Masoodi

Keywords

Related Articles

MicroRNAs as emerging diagnostic and prognostic marker in cancer biology and therapy

MicroRNAs (miRNAs) contribute to cellular homeostasis and differentiation in many ways and therefore play an important role in many pathophysiological events. The knowledge of small non-coding RNAmolecules has developed...

POLYSOMNOGRAPHY

Polysomnography (PSG) is the gold standard diagnostic test for several sleep disorders. It records, analyzes, & interprets multiple simultaneous physiologic characteristics during sleep. These parameters include brain wa...

A case series of patients with de novo Philadelphia-positive chronic myelogenous leukemia at tertiary care center SKIMS

The well-established molecular pathogenesis of chronic myelogenous leukemia (CML) and its consequences for laboratory testing and clinical management illustrate a classic paradigm for the importance of molecular diagnost...

Factors affecting operating time in resection of Rectal Cancer

Background:- Rectal cancer continues to be a challenging disease which most of the time needs proper staging and multimodal management to achieve the best possible cure rates. For operating surgeons, many factors may pla...

SPRINT: More Intensive Blood Pressure Management Saves Lives

A more intensive strategy of blood pressure management reduces the risk for death and cardiovascular events when compared with a strategy that lowers systolic blood pressure to the conventional target of 140 mm Hg, a lar...

Download PDF file
  • EP ID EP431523
  • DOI -
  • Views 80
  • Downloads 0

How To Cite

Shariq R. Masoodi (2017). Hepatitis in Developing Countries: Still a Scourge.. Journal of Medical Sciences, 20(2), 55-56. https://europub.co.uk./articles/-A-431523